De Luca D, Cogo P, Zecca E, Piastra M, Pietrini D, Tridente A, et al. Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review. Eur Respir J. 2011;37:678–89.

Article  PubMed  Google Scholar 

Rocha G. Inhaled pharmacotherapy for neonates: a narrative review. Turkish Arch Pediatr. 2022;57:5.

Article  Google Scholar 

Zhang L, Mendoza-Sassi RA, Klassen TP, Wainwright C. Nebulized hypertonic saline for acute bronchiolitis: a systematic review. Pediatrics. 2015;136:687–701.

Article  PubMed  Google Scholar 

Zhang L, Mendoza-Sassi RA, Wainwright CE, Aregbesola A, Klassen TP. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2023;4:CD006458.

PubMed  Google Scholar 

Rio MG, Gerhardt T, Hehre D, Feller R, Bancalari E. Effect of a beta‐agonist nebulization on lung function in neonates with increased pulmonary resistance. Pediatr Pulmonol. 1986;2:287–91.

Article  Google Scholar 

Smyth JA, Tabachnik E, Duncan WJ, Reilly BJ, Levison H. Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. Pediatrics. 1981;68:336–40.

Article  CAS  PubMed  Google Scholar 

Nelin LD, Kielt MJ, Jebbia M, Jadcherla S, Shepherd EG. Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia. ERJ Open Res. 2022;8:00682–2021.

Article  PubMed  PubMed Central  Google Scholar 

Ng G, da Silva O. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2016;12:CD003214.

PubMed  Google Scholar 

Guaman MC, Gien J, Baker CD, Zhang H, Austin ED, Collaco JM. Point prevalence, clinical characteristics, and treatment variation for infants with severe bronchopulmonary dysplasia. Am J Perinatol. 2015;32:960–7.

Article  PubMed  PubMed Central  Google Scholar 

Slaughter JL, Stenger MR, Reagan PB, Jadcherla SR. Inhaled bronchodilator use for infants with bronchopulmonary dysplasia. J Perinatol. 2015;35:61–6.

Article  CAS  PubMed  Google Scholar 

Bozzola E, Bozzola M, Barberi S, Cutrera R, Villani A. Safety and potential side effects of β2-agonists: a still debated question. Int J Pediatr Child Health. 2013;1:4–10.

Article  Google Scholar 

Woodward S, Mundorff M, Weng C, Gamboa DG, Johnson MD. Incidence of supraventricular tachycardia after inhaled short-acting beta agonist treatment in children. J Asthma. 2021;58:471–80.

Article  PubMed  Google Scholar 

Su E, Liew DF, Donnelly J, Elliott RA. Medicines stewardship. Aust Prescr. 2023;46:24.

Article  PubMed  PubMed Central  Google Scholar 

Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for Quality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2016;25:986–92.

Article  PubMed  Google Scholar 

Joosten T, Bongers I, Janssen R. Application of lean thinking to health care: issues and observations. Int J Qual Health Care. 2009;21:341–7.

Article  PubMed  PubMed Central  Google Scholar 

De Feo JA, Barnard W. Juran Institute’s Six Sigma: Breakthrough and Beyond: Quality Performance Breakthrough Methods. McGraw-Hill Professional; 2003.

Langley GJ, Moen RD, Nolan KM, Nolan TW, Norman CL, Provost LP. The improvement guide: a practical approach to enhancing organizational performance. John Wiley & Sons; 2009.

Provost LP, Murray SK The health care data guide: learning from data for improvement. John Wiley & Sons; 2022.

Perla RJ, Provost LP, Murray SK. The run chart: a simple analytical tool for learning from variation in healthcare processes. BMJ Qual Saf. 2011;20:46–51.

Article  PubMed  Google Scholar 

Gillis HC, Dolan K, Sargel CL, Thompson RZ, Lutmer JE. A quality improvement approach to influence value-based mucolytic use in the PICU. Pediatr Qual Saf. 2021;6:e438.

Article  PubMed  PubMed Central  Google Scholar 

Fleming K, George JL, Bazelak SJ, Roeske JA, Biggs AD, Landry CM, et al. Optimizing respiratory therapy resources by de-implementing low-value care. Respir Care. 2023;68:559–64.

Article  PubMed  PubMed Central  Google Scholar 

Elshaug AG, Rosenthal MB, Lavis JN, Brownlee S, Schmidt H, Nagpal S, et al. Levers for addressing medical underuse and overuse: achieving high-value health care. Lancet. 2017;390:191–202.

Article  PubMed  Google Scholar 

Bamat NA, Kirpalani H, Feudtner C, Jensen EA, Laughon MM, Zhang H, et al. Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children’s hospitals. J Perinatol. 2019;39:1291–9.

Article  PubMed  PubMed Central  Google Scholar